Dc. Angus et al., Epidemiology of severe sepsis in the United States: Analysis of incidence,outcome, and associated costs of care, CRIT CARE M, 29(7), 2001, pp. 1303-1310
Objective: To determine the incidence, cast, and outcome of severe sepsis i
n the United States.
Design: Observational cohort study.
Setting: All nonfederal hospitals (n = 847) in seven U.S. states.
Patients: All patients (n = 192,980) meeting criteria for severe sepsis bas
ed on the International Classification of Diseases, Ninth Revision, Clinica
l Modification.
Interventions: None.
Measurements and Main Results: We linked all 1995 state hospital discharge
records (n = 6,621,559) from seven large states with population and hospita
l data from the U.S. Census, the Centers for Disease Control, the Health Ca
re Financing Administration, and the American Hospital Association. We defi
ned severe sepsis as documented infection and acute organ dysfunction using
criteria based on the International Classification of Diseases, Ninth Revi
sion, Clinical Modification. We validated these criteria against prospectiv
e clinical and physiologic criteria in a subset of five hospitals. We gener
ated national age- and gender- adjusted estimates of incidence, cost, and o
utcome. We identified 192,980 cases, yielding national estimates of 751,000
Gases (3.0 cases per 1,000 population and 2.26 cases per 100 hospital disc
harges), of whom 383,000 (51.1%) received intensive care and an additional
130,000 (17.3%) were ventilated in an intermediate care unit or cared for i
n a coronary care unit. Incidence increased > 100-fold with age (0.2/1,000
in children to 26.2/1,000 in those > 85 yrs old). Mortality was 28.6%, or 2
15,000 deaths nationally, and also increased with age, from 10% in children
to 38.4% in those > 85 yrs old. Women had lower age-specific incidence and
mortality, but the difference in mortality was explained by differences in
underlying disease and the site of infection. The average costs per case w
ere $22,100, with annual total costs of $16.7 billion nationally. Costs wer
e higher in infants, nonsurvivors, intensive care unit patients, surgical p
atients, and patients with more organ failure. The incidence was projected
to increase by 1.5% per annum.
Conclusions: Severe sepsis is a common, expensive, and frequently fatal con
dition, with as many deaths annually as those from acute myocardial infarct
ion. It is especially common in the elderly and is likely to increase subst
antially as the U.S. population ages.